S&P 500

5.631,22

0,28%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

<< Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
12/06/2020	23h25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
12/06/2020	00h20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
10/06/2020	12h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
10/06/2020	02h45	PR Newswire (US)	Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ARDX	Ardelyx Inc
08/06/2020	23h17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
08/06/2020	22h01	PR Newswire (US)	Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer	NASDAQ:ARDX	Ardelyx Inc
03/06/2020	00h39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
26/05/2020	15h00	PR Newswire (US)	Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
21/05/2020	23h23	PR Newswire (US)	Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ARDX	Ardelyx Inc
20/05/2020	23h47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
18/05/2020	22h01	PR Newswire (US)	Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer	NASDAQ:ARDX	Ardelyx Inc
14/05/2020	01h26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
07/05/2020	22h09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARDX	Ardelyx Inc
07/05/2020	22h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
07/05/2020	22h02	PR Newswire (US)	Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights	NASDAQ:ARDX	Ardelyx Inc
06/05/2020	00h12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
28/04/2020	22h44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
27/04/2020	12h08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ARDX	Ardelyx Inc
27/04/2020	12h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ARDX	Ardelyx Inc
17/04/2020	13h30	GlobeNewswire Inc.	Knight Therapeutics Announces Approval of IBSRELA™ in Canada	NASDAQ:ARDX	Ardelyx Inc
07/04/2020	22h20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
17/03/2020	21h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
17/03/2020	00h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/03/2020	00h35	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc